239
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Total emitted dose of salbutamol sulphate at different inhalation flows and inhalation volumes through different types of dry powder inhalers

, , , , , , & ORCID Icon show all
Pages 211-216 | Received 04 Mar 2018, Accepted 11 Jun 2018, Published online: 22 Oct 2018

References

  • Haidl P, Heindl S, Siemon K, Bernacka M, Cloes RM. Inhalation device requirements for patients' inhalation maneuvers. Respir Med. 2016;118:65–75.
  • Alagusundaram M, Deepthi N, Ramkanth S, Angalaparameswari S, Saleem TM, Gnanaprakash K, et al. Dry powder inhalers-an overview. Int J Res Pharm Sci. 2010;1(1):34–42.
  • Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, et al. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med. 2011;105(6):930–938.
  • Laube BL, Janssens HM, de Jongh FH, Devadason SG, Dhand R, Diot P, et al. What the pulmonary specialist should know about the new inhalation therapies. Eur Respiratory Soc. 2011;37(6):1308–1331.
  • Al-Showair RA, Tarsin WY, Assi KH, Pearson SB, Chrystyn H. Can all patients with COPD use the correct inhalation flow with all inhalers and does training help? Respir Med. 2007;101(11):2395–2401.
  • Ross DL, Schultz RK. Effect of inhalation flow rate on the dosing characteristics of dry powder inhaler (DPI) and metered dose inhaler (MDI) products. J Aerosol Med. 1996;9(2):215–226.
  • Abdelrahim M, Assi K, Chrystyn H. Dose emission and aerodynamic characterization of the terbutaline sulphate dose emitted from a Turbuhaler at low inhalation flow. Pharm Dev Technol. 2013;18(4):944–949.
  • Palander A, Mattila T, Karhu M, Muttonen E. In vitro comparison of three salbutamol-containing multidose dry powder inhalers. Clin Drug Investig. 2000;20(1):25–33.
  • Ali AMA, Abdelrahim MEA. Modeling and optimization of terbutaline emitted from a dry powder inhaler and influence on systemic bioavailability using data mining technology. J Pharm Innov. 2014;9(1):38–47.
  • Nelson HS. Inhalation devices, delivery systems, and patient technique. Ann Allergy Asthma Immunol. 2016;117(6):606–612.
  • Abdelrahim ME. Emitted dose and lung deposition of inhaled terbutaline from Turbuhaler at different conditions. Respir Med. 2010;104(5):682–689.
  • Hassan A, Rabea H, Hussein RR, Eldin RS, Abdelrahman MM, Said AS, et al. In vitro characterization of the aerosolized dose during non-invasive automatic continuous positive airway pressure ventilation. Pul Ther. 2016;2(1):115–126.
  • Pedersen S, Hansen O, Fuglsang G. Influence of inspiratory flow rate upon the effect of a Turbuhaler. Arch Dis Child. 1990;65(3):308–310.
  • Nielsen K, Skov M, Klug B, Ifversen M, Bisgaard H. Flow-dependent effect of formoterol dry-powder inhaled from the Aerolizer. Eur Respir J. 1997;10(9):2105–2109.
  • Buttini F, Colombo P, Rossi A, Sonvico F, Colombo G. Particles and powders: tools of innovation for non-invasive drug administration. J Control Release. 2012;161(2):693–702.
  • Buttini F, Brambilla G, Copelli D, Sisti V, Balducci AG, Bettini R, et al. Effect of flow rate on in vitro aerodynamic performance of NEXThaler® in comparison with Diskus® and Turbohaler® Dry Powder Inhalers. J Aerosol Med Pulm Drug Deliv. 2016;29(2):167–178.
  • Shur J, Harris H, Jones MD, Kaerger JS, Price R. The role of fines in the modification of the fluidization and dispersion mechanism within dry powder inhaler formulations. Pharm Res. 2008;25(7):1631–1640.
  • Shur J, Lee S, Adams W, Lionberger R, Tibbatts J, Price R. Effect of device design on the in vitro performance and comparability for capsule-based dry powder inhalers. AAPS J. 2012;14(4):667–676.
  • Clark A, Hollingworth A. The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers—implications for in vitro testing. J Aerosol Med. 1993;6(2):99–110.
  • Kamin W, Genz T, Roeder S, Scheuch G, Trammer T, Juenemann R, et al. Mass output and particle size distribution of glucocorticosteroids emitted from different inhalation devices depending on various inspiratory parameters. J Aerosol Med. 2002;15(1):65–73.
  • Amirav I, Newhouse MT, Mansour Y. Measurement of peak inspiratory flow with in‐check dial device to simulate low‐resistance (Diskus) and high‐resistance (Turbohaler) dry powder inhalers in children with asthma. Pediatr Pulmonol. 2005;39(5):447–451.
  • Madney YM, Fathy M, Elberry AA, Rabea H, Abdelrahim M, Hassan A, et al. Abstracts: International Society for Aerosols in Medicine eV 21st ISAM Congress Santa Fe, NM June 3–7, 2017. J Aerosol Med Pulm Drug Deliv. 2017;30(3):A1–A38.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.